Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential. | Int J Mol Sci | 2021 | 34884721 | PubTator, text mining | PubMed |
| The Role of EREG/EGFR Pathway in Tumor Progression. | Int J Mol Sci | 2021 | 34884633 | PubTator, text mining | PubMed |
| Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19. | Int J Mol Sci | 2021 | 34884604 | PubTator, text mining | PubMed |
| Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases. | Int J Mol Sci | 2021 | 34884494 | PubTator, text mining | PubMed |
| Supraphysiological Role of Melatonin Over Vascular Dysfunction of Pregnancy, a New Therapeutic Agent? | Front Physiol | 2021 | 34867473 | PubTator, text mining | PubMed |
| Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway. | Front Pharmacol | 2021 | 34867394 | PubTator, text mining | PubMed |
| The microenvironment of brain metastases from solid tumors. | Neurooncol Adv | 2021 | 34859239 | PubTator, text mining | PubMed |
| Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology. | Sci Rep | 2021 | 34845218 | PubTator, text mining | PubMed |
| Agonist/Antagonist Activity of Oxytocin Variants Obtained from Free Cyclic Peptide Libraries Generated via Amino Acid Substitution. | ACS Omega | 2021 | 34841168 | PubTator, text mining | PubMed |
| Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? | Vaccines (Basel) | 2021 | 34835284 | PubTator, text mining | PubMed |
| Specific Autoantibodies in Neovascular Age-Related Macular Degeneration: Evaluation of Morphological and Functional Progression over Five Years. | J Pers Med | 2021 | 34834560 | PubTator, text mining | PubMed |
| Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials. | Pharmaceutics | 2021 | 34834162 | PubTator, text mining | PubMed |
| The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection. | Cells | 2021 | 34831300 | PubTator, text mining | PubMed |
| Mechanisms, Diagnosis and Treatment of Bone Metastases. | Cells | 2021 | 34831167 | PubTator, text mining | PubMed |
| Kinase-Inhibitors in Iodine-Refractory Differentiated Thyroid Cancer-Focus on Occurrence, Mechanisms, and Management of Treatment-Related Hypertension. | Int J Mol Sci | 2021 | 34830100 | PubTator, text mining | PubMed |
| Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. | Biomedicines | 2021 | 34829764 | PubTator, text mining | PubMed |
| Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study. | Genes (Basel) | 2021 | 34828420 | PubTator, text mining | PubMed |
| Revisiting the Large-Conductance Calcium-Activated Potassium (BKCa) Channels in the Pulmonary Circulation. | Biomolecules | 2021 | 34827626 | PubTator, text mining | PubMed |
| Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. | Front Pharmacol | 2021 | 34803696 | PubTator, text mining | PubMed |
| SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene. | Immune Netw | 2021 | 34796036 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=48